How Much Does It Cost to Defend My Case?

The number you want is a number this article cannot provide with any responsibility. Not because the information is proprietary, and not because the answer is “it depends” (though the answer is, in every meaningful sense, contingent on variables that alter the figure by orders of magnitude), but because a physician who receives a target letter or an Order to Show Cause and begins the search for counsel by asking what the defense will cost has organized the inquiry around the wrong axis. The cost of the defense is a function of the defense. The defense is a function of the case. The case is a function of what the government has assembled, what the physician’s records contain, and how many institutional forums have opened proceedings simultaneously. You do not price a defense the way you price a procedure. You price it the way you price a course of treatment whose duration depends on what the diagnostic workup reveals.

Physicians deserve honest figures. What follows is an attempt to provide them.

The Ranges Are Real and They Are Wide

A federal criminal defense attorney with experience in healthcare fraud prosecutions charges between $350 and $800 per hour. Retainers for pre-indictment representation in opioid prescribing investigations begin at $25,000 and extend to $75,000 depending on geographic jurisdiction and the volume of records involved. If the matter proceeds to indictment, the total legal fees for a case that resolves through plea negotiation fall, in most instances we have observed, between $150,000 and $350,000. If the matter proceeds to trial, the figure rises to between $500,000 and $1,000,000, and in multi-defendant conspiracies with extensive discovery, depositions, and a trial lasting several weeks, the total can exceed that ceiling without the attorney having done anything extravagant, because the defense of a federal healthcare fraud prosecution at trial requires the review of thousands of patient charts, the retention and preparation of medical experts and forensic accountants, the analysis of ARCOS data and PDMP records and billing histories that the government spent years assembling with resources the physician cannot match.

In nine of the twelve opioid prescribing matters our firm resolved in the eighteen months preceding this writing, the total defense cost including expert fees fell below $400,000. Three exceeded that figure. One exceeded $750,000. The variable in each instance was not the attorney’s hourly rate but the phase at which the physician retained counsel and the number of institutional proceedings that had opened by the time the representation commenced.

The Expert Witnesses Constitute a Separate Expenditure

The defense of an opioid prescribing case under the Ruan v. United States framework requires expert testimony on the clinical standard that governed the physician’s prescribing decisions. This is not an optional component. It is, or ought to be, the structural center of the defense, because Ruan requires the government to prove that the physician knew or intended the prescribing to be unauthorized, and the primary instrument for demonstrating that the physician possessed a genuine clinical basis for each prescription is a medical expert who can reconstruct the reasoning that preceded each prescribing decision from the patient charts the government has already seized.

Medical expert witnesses in controlled substance cases charge between $400 and $600 per hour for case review and between $5,000 and $15,000 per day for trial testimony. A case involving forty patients whose charts require individual analysis will generate expert fees of $50,000 to $150,000. Forensic accountants, whose testimony may be necessary to challenge the government’s loss calculations under U.S.S.G. Section 2B1.1 or to demonstrate that the practice’s revenue derived from legitimate clinical services rather than from the prescribing conduct at issue, charge $300 to $450 per hour. Biostatistical experts retained to challenge PDMP or ARCOS data interpretations charge comparable rates.

The total expert cost in a case that proceeds to trial with two or three retained experts and one forensic accountant falls, if we are being precise, not in the range most physicians anticipate when they contemplate the expense of a legal proceeding but in a range that resembles the capitalization cost of a small clinical practice. The comparison is not incidental.

Administrative Defense Costs Less but Protects the Thing That Matters Most

A DEA administrative proceeding to revoke or suspend a controlled substance registration is not a criminal prosecution. The evidentiary standard is a preponderance rather than proof beyond a reasonable doubt. The procedural rules are relaxed. The hearing occurs before an administrative law judge whose recommended decision is not binding on the DEA Administrator. The defense of a Show Cause hearing, from preparation through hearing and post-hearing briefing, costs between $75,000 and $200,000 in most cases, a fraction of the criminal defense cost.

The registration, however, is the practice. Without a DEA registration, a pain management physician or a psychiatrist or a pharmacist cannot perform the clinical functions that constitute the substance of a professional life. Revocation is permanent. State medical boards treat it as independent grounds for disciplinary action. Hospital credentialing committees respond to it. Insurance panels terminate participation. The cascade operates with an institutional momentum that no subsequent proceeding arrests.

A physician who invests $500,000 in a criminal defense and permits the administrative proceeding to resolve by default because the registration seemed like a secondary concern has preserved the ability to remain outside of a federal institution while surrendering the ability to practice the profession that made the institution worth avoiding. The order of priority is not as self-evident as it appears.

Whether the administrative proceeding should be contested when a parallel criminal investigation is active, or whether the testimony offered in the administrative forum will migrate to the criminal prosecution with consequences that outweigh the value of preserving the registration, is a question whose answer depends on facts specific to each case and on strategic judgments that competent counsel must make with the physician’s full circumstances in view. This is among the reasons the hourly rate of the attorney matters less than the architecture of the representation.

Insurance Covers Almost None of It

Physicians assume their professional liability insurance will cover the cost of defending a DEA investigation or a federal prosecution. The assumption is incorrect in almost every instance. Standard medical malpractice policies include a regulatory defense sublimit, typically $25,000, occasionally $50,000, that applies to administrative proceedings initiated by the DEA, state medical boards, or other regulatory bodies. The sublimit is consumed before the hearing preparation is complete. It does not apply to criminal defense costs. It does not cover expert witness fees. It does not extend to parallel civil proceedings under the False Claims Act.

Some carriers offer supplemental regulatory defense endorsements that raise the sublimit to $100,000 or $150,000. These endorsements exist. They are not standard. Most physicians do not carry them because most physicians do not contemplate a DEA investigation until one commences, at which point the policy terms are fixed and the coverage gap is a fact rather than a contingency.

The financial architecture of the defense, then, falls on the physician. This is the reality that produces the most consequential decisions in our experience: not whether to retain counsel, but when, and whether to invest in the phase of the proceeding where the expenditure is smallest and the influence on outcome is greatest, or to defer and discover that the later phase costs more and offers less.

Early Intervention Alters the Arithmetic

The government’s investigation of a prescribing physician unfolds over months or years before the physician becomes aware of it. ARCOS data analysis, PDMP pattern review, confidential informant reports, patient interviews, controlled purchases through undercover agents posing as patients. By the time a target letter arrives or a search warrant is executed, the government’s theory is formed. The evidence is assembled. The institutional commitment to prosecution has been made.

Representation retained at the pre-indictment phase, before the grand jury has returned charges, occupies a position on the timeline where the defense can present clinical context to the assigned AUSA, can commission a privileged compliance audit that demonstrates the physician’s good faith, can negotiate the scope and terms of document production, and can prevent the physician from submitting to a voluntary interview whose memorialization in a DEA-6 report becomes an exhibit the government introduces at every subsequent stage of the proceeding. Pre-indictment advocacy costs $25,000 to $100,000 in most matters. It is the smallest figure in this article, and it corresponds to the phase of the proceeding where the defense possesses its greatest capacity to alter the outcome.

You pay the least at the moment when the money does the most. That is the inversion most physicians do not perceive until the moment has closed.

The Cost of Not Defending

Criminal forfeiture under 21 U.S.C. 853 reaches every asset derived from or used to facilitate the distribution the government proves at trial: the practice, the real estate, the bank accounts, the personal residence if purchased with practice revenue. Civil asset forfeiture requires probable cause, not a conviction, and can freeze accounts while the criminal case is pending, which produces the perverse consequence of depriving the physician of the resources to mount the defense before the defense has commenced. OIG exclusion from Medicare and Medicaid, which is mandatory upon felony conviction for unlawful distribution, eliminates the financial foundation of any practice that serves federal program beneficiaries. The system permits the physician to apply for reinstatement after five years. The system also ensures that the five years render reinstatement largely theoretical. The National Practitioner Data Bank records the action. The reporting follows the physician indefinitely.

Against these figures, the cost of a defense that preserves the registration, prevents the indictment, or secures an acquittal at trial is not an expenditure in the ordinary sense. It functions the way a retaining wall functions along a hillside where the soil has begun to shift: the cost of the wall is a number, but the cost of its absence is the property. Whether the metaphor overstates the case depends on facts particular to the physician’s circumstances. In most cases we have reviewed, it does not.

DEFENSE TEAM SPOTLIGHT

Todd Spodek

Lead Attorney & Founder

Featured on Netflix's "Inventing Anna," Todd Spodek brings decades of high-stakes criminal defense experience. His aggressive approach has secured dismissals and acquittals in cases others deemed unwinnable.

NY Bar Admitted Multi-State Licensed Federal Courts

Meet the Full Team

Fee Structures Vary and the Variance Matters

Some firms charge flat fees for defined phases of representation: pre-indictment advocacy, administrative hearing preparation and attendance, plea negotiation, trial. Flat fees provide cost certainty and are common in administrative proceedings where the scope of the hearing can be estimated with reasonable precision. Other firms charge hourly with an initial retainer that is replenished as the balance diminishes, a structure that accommodates the unpredictable duration of federal criminal proceedings but exposes the physician to costs that accumulate without a contractual ceiling. A smaller number of firms employ hybrid arrangements: a flat fee through a defined phase with hourly billing if the matter extends beyond that phase.

The fee structure should be discussed before the engagement commences. It should be documented in writing. The physician should understand not only the initial retainer but the anticipated total cost under various scenarios: resolution at the pre-indictment stage, resolution through plea, resolution at trial. A firm that cannot provide these estimates has either not handled enough of these matters to know the ranges or has chosen not to disclose them, and in either case the physician is entering a financial commitment whose dimensions remain obscure.

The retainer agreement is a contract. It merits the same scrutiny a physician would apply to a lease or an employment agreement. Most physicians do not apply that scrutiny, because the urgency of the legal situation compresses the deliberation that the financial commitment warrants.

What the Question Reveals

The physician who asks “how much will this cost” is asking a question that contains, compressed inside it, a series of questions the physician has not yet formulated: how long will this take, how exposed am I, what is the worst outcome, can I continue to practice while this is pending, will I lose everything I have constructed over a career that began with a residency and has arrived at this conference room where an attorney is discussing fees. The cost question is the surface. The architecture beneath it is the physician’s entire professional life held in suspension, awaiting a resolution whose contours depend on decisions that have not yet been made.

The consultation is where those decisions acquire their preliminary form. It is not a commitment. It is a diagnostic encounter, conducted with the same purpose that governs the physician’s own first meeting with a patient whose presenting complaint is a fraction of the clinical picture. The consultation is where the cost question receives an answer grounded in the specific facts of the physician’s situation rather than in the ranges this article has provided, which are accurate as generalizations and insufficient as guidance for any particular case.

The federal enforcement apparatus does not diminish in scale or in resources. The 2025 National Health Care Fraud Takedown charged 324 defendants across fifty federal districts. Operation Profit Over Patients resulted in 51 arrests and 122 criminal charges alongside 93 administrative actions. The government commits institutional resources to these prosecutions measured in the tens of millions. The physician’s commitment to the defense is measured in a fraction of that figure, directed toward the preservation of something the government’s resources are designed to dismantle. The disproportion is permanent. The question is not whether to invest in the defense but whether to invest early enough, and with sufficient precision, that the investment corresponds to the phase of the proceeding where it possesses the capacity to alter what follows.